HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma
Clinical trial NCT01856023 · TERMINATED
Trial details
- NCT number
- NCT01856023
- Sponsor
- Clinigen, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2015-07-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.